Evaluation of the Antifungal and Wound-Healing Properties of a Novel Peptide-Based Bioadhesive Hydrogel Formulation

• Published in: Antimicrobial agents and chemotherapy 2019-10, Vol.63 (10)
• Main Authors: Sultan, Ahmed S, Vila, Taissa, Hefni, Eman, Karlsson, Amy J, Jabra-Rizk, Mary Ann
• Format: Article
• Language: English
• Subjects: Anti-Infective Agents; Antifungal Agents; Experimental Therapeutics; Hydrogels; Peptides; Wound Healing
• ISSN: 0066-4804; 1098-6596
• DOI: 10.1128/AAC.00888-19

Oral candidiasis (OC) caused by the fungal pathogen is the most common opportunistic infection in immunocompromised populations. The dramatic increase in resistance to common antifungal agents has emphasized the importance of identifying alternative therapeutic options. Antimicrobial peptides have emerged as promising drug candidates due to their antimicrobial properties; specifically, histatin-5 (Hst-5), a peptide naturally produced and secreted by human salivary glands, has demonstrated potent activity against However, as we previously demonstrated vulnerability for Hst-5 to proteolysis by proteolytic enzymes at specific amino acid residues, a new variant (K11R-K17R) was designed with amino acid substitutions at the identified cleavage sites. The new resistant peptide demonstrated no cytotoxicity to erythrocytes or human oral keratinocytes. To evaluate the potential of the new peptide for clinical application, we utilized our FDA-approved polymer-based bioadhesive hydrogel as a delivery system and developed a therapeutic formulation specifically designed for oral topical application. The new formulation was demonstrated to be effective against strains resistant to the traditional antifungals, and the therapeutic efficacy was found to be comparable to that of the common topical antifungal agents in clinical use. Importantly, in addition to its antifungal properties, our findings also demonstrated that the new peptide variant induces cell proliferation and rapid cell migration of human oral keratinocytes, indicative of wound healing properties. The findings from this study support the progression of the novel formulation as a therapeutic agent against oral candidiasis, as well as a therapeutic modality for promoting wound healing.